Amicus Therapeutics is a New Jersey-based biotechnological company that focuses on developing therapies to treat orphan and rare diseases. While pharmaceutical groups around the world are producing medication and treatments that few can afford, Amicus Therapeutics makes it a point to keep all of their developments affordable, for the people who really need them. And even though their corporate headquarters is located in New Jersey, they have locations in England, the Netherlands, Italy, Germany, and France, making their treatments available worldwide.
The goals that Amicus Therapeutics strive continually towards are part of what sets them apart from other companies that say they are trying to do the same thing. They fight to be on the forefront of discoveries that will change the lives of their patients. They never stop at “good enough”, but push for the best possible solution, making obsolete what everyone thought was the only option (YourBeautyCraze).
Amicus Therapeutics not only puts in every available effort to make life better for their patients but also invests in their future by building long-term value for their stakeholders. They find the perfect balance between a business setting and a scientific community, making sure that neither part is neglected or placed on a higher pedestal than the other. This way, the therapies that sufferers of these rare and orphan diseases are wholly dependent on will never suddenly disappear because of a lack of monetary backing or economic support.
Another of the many reasons that Amicus Therapeutics can put every ounce of their effort into improving the lives of others, is their dedication to the fair treatment of everyone on their team (http://releasefact.com/2017/08/amicus-therapeutics-funds-its-ground-breaking-new-treatment/). They can make these life-changing discoveries because they respect the accomplishments and opinions of each individual. Each person they employ can not only expect fair and respectful treatment for themselves but also their families. This creates a positive outlook that means every employee truly cares about the work they are doing, without being looked down upon. Because Amicus Therapeutics cares for their patients, their employees, and every single person involved in the process of changing lives for the better.
Dr. Mark Holterman is one of the renowned figures in the medical arena. He is an accomplished medical practitioner, researcher, and educator. Dr. Mark Holterman works as a professor at the University of Illinois and also as the CEO of Mariam Global Health. Dr. Mark Holterman has dedicated his life to helping medical students and patients in various ways.
Dr. Mark Holterman supports various charitable organizations such as the IPSAC-VN. IPSAC-VN is a charity comprising of Pediatric Specialists who offer medical support to underprivileged children in Vietnam. Vietnam primarily relies on the support of volunteers and donors who help to improve access to pediatric surgical care, in particular among the disadvantaged children.
Dr. Mark Holterman is an active participant of the IPSAC-VN charitable cause. As a volunteer, Dr. Mark Holterman offer the most needed hands-on support by providing patient care, lecturing, training, and surgery at affiliated hospitals and medical schools in Vietnam. Volunteers willing to participate in the IPSAC-VN must acquire a visa and passport with a validity period of at least six months after the date of the trip. Additionally, volunteers involved in the IPSAC-VN must provide copies of their license and CV.
Once the application is accepted, the volunteers are then required to purchase travel medical insurance which covers them for the period they are away from home (Twitter). The volunteers participating in the IPSAC-VN charitable cause are advised at least two days before the date they are scheduled to begin volunteering. Travelling a few days before helps the volunteers to familiarize with the culture and people. The volunteers are expected to take care of their travel, accommodation, food, and other expenses while in Vietnam.
About Dr. Mark Holterman
Dr. Mark Holterman has studied regenerative medicine and practiced pediatric surgery for a couple of years. Mark Holterman spends a lot of his time conducting medical research on various areas. He is also a professor at the University of Illinois where he teaches surgery.
Besides, Dr. Mark Holterman provides pediatric care to surgical patients at St. Francis Medical Center. Mark Holterman, MD, has earned several accolades that include the coveted Innovative Research Award which was awarded by the American Diabetes Association.
More on LinkedIn